Madrigal Pharmaceuticals (MDGL) Intangibles (2024 - 2026)

Madrigal Pharmaceuticals (MDGL) has 3 years of Intangibles data on file, last reported at $7.3 million in Q1 2026.

• On a quarterly basis, Intangibles rose 57.02% year-over-year to $7.3 million in Q1 2026; TTM through Mar 2026 was $7.3 million, a 57.02% increase from a year earlier, with the FY2025 full-year figure at $7.4 million, up 56.08% from the prior year.
• Intangibles for Q1 2026 stood at $7.3 million, down from $7.4 million in the prior quarter.
• Over the last five years, Intangibles for MDGL reached as high as $7.5 million in Q3 2025 and fell as low as $4.5 million in Q2 2025.
• Historically, Intangibles has averaged $5.6 million across 3 years, with a median of $4.9 million in 2024.
• Across the five-year window, Intangibles retreated 7.37% in 2025 and jumped 57.02% in 2026, its largest moves.
• Year by year, Intangibles stood at $4.7 million in 2024, then soared by 56.08% to $7.4 million in 2025, then declined by 1.31% to $7.3 million in 2026.
• Per Business Quant data, the three most recent Intangibles figures were $7.3 million in Q1 2026, $7.4 million in Q4 2025, and $7.5 million in Q3 2025.